Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sophia Boyoung Strobel"'
Autor:
Wolfgang Eich, Christiane Bieber, Beate Wild, Martin Salzmann, Friedegund Meier, Julia Bossert, Pia Grabbe, Imad Maatouk, Kathrin Gschwendtner, Sophia Boyoung Strobel, Jessica C. Hassel
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-11 (2021)
Trials
Trials
Background Patients with metastatic melanoma and their physicians are confronted with a complex decision regarding first-line therapy. Risks and benefits vary considerably between various treatment options. With this in mind, we aim to develop and ev
Autor:
Thomas, Walle, Sunanjay, Bajaj, Joscha A, Kraske, Thomas, Rösner, Christiane S, Cussigh, Katharina A, Kälber, Lisa Jasmin, Müller, Sophia Boyoung, Strobel, Jana, Burghaus, Stefan M, Kallenberger, Christoph K, Stein-Thöringer, Maximilian, Jenzer, Antonia, Schubert, Steffen, Kahle, Anja, Williams, Birgit, Hoyler, Lin, Zielske, Renate, Skatula, Stefanie, Sawall, Mathias F, Leber, Russell Z, Kunes, Johannes, Krisam, Carlo, Fremd, Andreas, Schneeweiss, Jürgen, Krauss, Leonidas, Apostolidis, Anne Katrin, Berger, Georg M, Haag, Stefanie, Zschäbitz, Niels, Halama, Christoph, Springfeld, Romy, Kirsten, Jessica C, Hassel, Dirk, Jäger
Publikováno v:
Nature cancer. 3(9)
Patients with cancer frequently receive immune-checkpoint inhibitors (ICIs), which may modulate immune responses to COVID-19 vaccines. Recently, cytokine release syndrome (CRS) was observed in a patient with cancer who received BTN162b2 vaccination u
Autor:
Jessica C. Hassel, Dirk Jäger, Devayani Machiraju, Michael Bachmann, Winfried S. Wels, Annette Paschen, Ingrid Hülsmeyer, Jürgen C. Becker, Sophia Boyoung Strobel
Publikováno v:
Life
Volume 11
Issue 4
Life, Vol 11, Iss 269, p 269 (2021)
Volume 11
Issue 4
Life, Vol 11, Iss 269, p 269 (2021)
Tumor antigen-specific redirection of cytotoxic T cells (CTLs) or natural killer (NK) cells including chimeric antigen receptor (CAR-) and T cell receptor (TCR-) cell therapy is currently being evaluated in different tumor entities including melanoma
Autor:
Alexander Enk, Lisa Zimmer, Sophia Boyoung Strobel, Alexandra Jensen, Jessica C. Hassel, Sylvie Pätzold
Background Increased skin toxicity during combination therapy with a BRAF inhibitor and radiation therapy has recently been reported. Material and Methods We present seven melanoma patients with non-resectable stage III or IV disease and concomitant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c9013f37edeb2396ba90c87beb0952
https://www.ncbi.nlm.nih.gov/pubmed/28557366
https://www.ncbi.nlm.nih.gov/pubmed/28557366
Autor:
Sophia Boyoung, Strobel, Sylvie, Pätzold, Lisa, Zimmer, Alexandra, Jensen, Alexander, Enk, Jessica Cecile, Hassel
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 15(7)
In der letzten Zeit wurden in der Literatur vermehrt erhöhte Hauttoxizitäten während einer Kombinationstherapie mit BRAF Inhibitoren und Radiotherapie beschrieben.Wir berichten über sieben Melanompatienten in einem nicht resezierbaren Stadium III